MA47729A - Inhibiteurs de bêta-sécrétase - Google Patents
Inhibiteurs de bêta-sécrétaseInfo
- Publication number
- MA47729A MA47729A MA047729A MA47729A MA47729A MA 47729 A MA47729 A MA 47729A MA 047729 A MA047729 A MA 047729A MA 47729 A MA47729 A MA 47729A MA 47729 A MA47729 A MA 47729A
- Authority
- MA
- Morocco
- Prior art keywords
- beta
- secretase inhibitors
- secretase
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762468052P | 2017-03-07 | 2017-03-07 | |
EP17189762 | 2017-09-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA47729A true MA47729A (fr) | 2020-01-15 |
Family
ID=61616993
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA047729A MA47729A (fr) | 2017-03-07 | 2018-03-06 | Inhibiteurs de bêta-sécrétase |
Country Status (9)
Country | Link |
---|---|
US (1) | US20200010482A1 (fr) |
EP (1) | EP3592750A1 (fr) |
JP (1) | JP2020509068A (fr) |
KR (1) | KR20190126345A (fr) |
CN (1) | CN110418793A (fr) |
AU (1) | AU2018229721A1 (fr) |
CA (1) | CA3051764A1 (fr) |
MA (1) | MA47729A (fr) |
MX (1) | MX2019010649A (fr) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR077277A1 (es) * | 2009-07-09 | 2011-08-17 | Lilly Co Eli | Compuestos de biciclo (1,3)tiazin-2-amina formulacion farmaceutica que lo comprende y su uso para la manufactura de un medicamento util para el tratamiento de la enfermedad de alzheimer |
JPWO2011071109A1 (ja) * | 2009-12-11 | 2013-04-22 | 塩野義製薬株式会社 | アミノ基を有する縮合ヘテロ環化合物 |
US9556135B2 (en) * | 2012-10-12 | 2017-01-31 | Amgen, Inc. | Amino-dihydrothiazine and amino-dioxido dihydrothiazine compounds as beta-secretase antagonists and methods of use |
-
2018
- 2018-03-06 JP JP2019548602A patent/JP2020509068A/ja active Pending
- 2018-03-06 MA MA047729A patent/MA47729A/fr unknown
- 2018-03-06 CA CA3051764A patent/CA3051764A1/fr not_active Abandoned
- 2018-03-06 KR KR1020197028598A patent/KR20190126345A/ko unknown
- 2018-03-06 CN CN201880016454.4A patent/CN110418793A/zh active Pending
- 2018-03-06 AU AU2018229721A patent/AU2018229721A1/en not_active Abandoned
- 2018-03-06 US US16/489,885 patent/US20200010482A1/en not_active Abandoned
- 2018-03-06 EP EP18709999.9A patent/EP3592750A1/fr not_active Withdrawn
- 2018-03-06 MX MX2019010649A patent/MX2019010649A/es unknown
Also Published As
Publication number | Publication date |
---|---|
EP3592750A1 (fr) | 2020-01-15 |
KR20190126345A (ko) | 2019-11-11 |
JP2020509068A (ja) | 2020-03-26 |
AU2018229721A1 (en) | 2019-08-15 |
MX2019010649A (es) | 2019-10-21 |
US20200010482A1 (en) | 2020-01-09 |
CA3051764A1 (fr) | 2018-09-13 |
CN110418793A (zh) | 2019-11-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA54543A (fr) | Inhibiteurs de kif18a | |
MA54550A (fr) | Inhibiteurs de kif18a | |
DK3731771T3 (da) | V462033dk00 | |
DK3612525T3 (da) | Pd-1-/pd-l1-inhibitorer | |
DK3497103T3 (da) | Pyridopyrimdinon-cdk2/4/6-inhibitorer | |
DK3442972T3 (da) | Bromdomænehæmmere | |
MA52812A (fr) | Inhibiteurs de sarm1 | |
DE202018003363U8 (de) | Handgelenkssphygmomanometer | |
DK3672976T3 (da) | Bcl-2-hæmmere | |
CL2018000524S1 (es) | Golilla | |
MA46857A (fr) | Inhibiteurs de magl | |
DK3571192T3 (da) | Jak1-selektive inhibitorer | |
DK3681884T3 (da) | Rad51-inhibitorer | |
CU20160125A7 (es) | Inhibidores de diacilglicerol aciltransferasa 2 | |
MA46860A (fr) | Inhibiteurs de magl | |
DK3351526T3 (da) | Diisopentylterephthalat | |
MA46855A (fr) | Inhibiteurs de magl | |
DK3630744T3 (da) | Pyrazol-magl-inhibitorer | |
MA43367A (fr) | Inhibiteurs de métallo-bêta-lactamases | |
DK3571580T3 (da) | Load-logical-and-shift-guarded-instruktion | |
MA52813A (fr) | Inhibiteurs de sarm1 | |
DK3568655T3 (da) | Rekuperator | |
MA52809A (fr) | Inhibiteurs de sarm1 | |
MA46280A (fr) | Inhibiteurs de la dopamine-b-hydroxylase | |
DK3612237T3 (da) | Genterapi |